Valeant files annual report, says in compliance with covenants

The headquarters of Valeant Pharmaceuticals International Inc is seen in Laval, Quebec in this file picture taken November 9, 2015. REUTERS/Christinne Muschi/Files

Thomson Reuters

(Reuters) - Beleaguered Canadian drugmaker Valeant Pharmaceuticals International Inc filed its annual report on Friday, which will help it stave of a default on its $30 billion debt.

The company said it was in compliance with its credit agreement and senior note indentures.

Valeant said no additional restatements were required beyond those previously disclosed.

(Reporting by Natalie Grover in Bengaluru; Editing by Savio D'Souza)

See Also:

• The US has a great reason to expect gasoline demand to stay sky-high

• Russia and Syria sign deals worth $850 million to restore Syrian infrastructure

• The offices of Mossack Fonseca got raided